Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1992 Oct;90(1):56–62. doi: 10.1111/j.1365-2249.1992.tb05831.x

Haemodialysis as a model for studying endogenous plasma DNA: oligonucleosome-like structure and clearance.

P Rumore 1, B Muralidhar 1, M Lin 1, C Lai 1, C R Steinman 1
PMCID: PMC1554541  PMID: 1395101

Abstract

The rate of clearance of extracellular plasma DNA in man has important implications for pathogenetic mechanisms in systemic lupus erythematosus (SLE), as well as for certain other clinical states. Present knowledge of this parameter is derived exclusively from studies of injected, naked DNA in animals. Recent information indicates that the physiologic form of plasma DNA in SLE is that of oligonucleosome-like molecules rather than of naked DNA and consists of multimeric complexes of DNA bound to histone, probably arising from an apoptotic process. In order to study the rate at which these oligonucleosome-like complexes are removed from plasma and to do so in man rather than experimental animals, we exploited the observation that during haemodialysis large amounts of DNA are released, apparently within the dialysis coil, into the patient's plasma. Since this release appears to cease promptly with termination of the procedure, it offered the potential for estimating the rate of removal of such DNA from human plasma. Moreover, if that DNA, as postulated, were shown to possess an oligonucleosome-like structure resembling that found endogenously in human SLE, the relevance of such information to the human disease state would be further enhanced. The present results support the conclusion that DNA released into plasma during haemodialysis possesses such an oligonucleosome-like structure. The plasma half-life of that DNA in man was found not to exceed 4 min. The highly dynamic state thus implied for extracellular endogenous plasma DNA in man has important implications for pathogenetic mechanisms dependent on dsDNA in SLE. Moreover, individuals undergoing chronic haemodialysis, who are thereby exposed to a very large cumulative amount of such DNA, might serve as models for studying its long-term sequelae.

Full text

PDF
56

Images in this article

58Fig. 1
on p.58
59Fig. 2
on p.59

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ali R., Dersimonian H., Stollar B. D. Binding of monoclonal anti-native DNA autoantibodies to DNA of varying size and conformation. Mol Immunol. 1985 Dec;22(12):1415–1422. doi: 10.1016/0161-5890(85)90065-3. [DOI] [PubMed] [Google Scholar]
  2. Bakayev V. V., Bakayeva T. G., Varshavsky A. J. Nucleosomes and subnucleosomes: heterogeneity and composition. Cell. 1977 Jul;11(3):619–629. doi: 10.1016/0092-8674(77)90079-4. [DOI] [PubMed] [Google Scholar]
  3. Bell D. A., Morrison B., VandenBygaart P. Immunogenic DNA-related factors. Nucleosomes spontaneously released from normal murine lymphoid cells stimulate proliferation and immunoglobulin synthesis of normal mouse lymphocytes. J Clin Invest. 1990 May;85(5):1487–1496. doi: 10.1172/JCI114595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chused T. M., Steinberg A. D., Talal N. The clearance and localization of nucleic acids by New Zealand and normal mice. Clin Exp Immunol. 1972 Dec;12(4):465–476. [PMC free article] [PubMed] [Google Scholar]
  5. Cosio F. G., Hebert L. A., Birmingham D. J., Dorval B. L., Bakaletz A. P., Kujala G. A., Edberg J. C., Taylor R. P. Clearance of human antibody/DNA immune complexes and free DNA from the circulation of the nonhuman primate. Clin Immunol Immunopathol. 1987 Jan;42(1):1–9. doi: 10.1016/0090-1229(87)90167-x. [DOI] [PubMed] [Google Scholar]
  6. Davis G. L., Jr, Davis J. S., 4th Detection of circulating DNA by counterimmunoelectrophoresis (CIE). Arthritis Rheum. 1973 Jan-Feb;16(1):52–58. doi: 10.1002/art.1780160108. [DOI] [PubMed] [Google Scholar]
  7. Dennin R. H. DNA of free and complexed origin in human plasma: concentration and length distribution. Klin Wochenschr. 1979 May 3;57(9):451–456. doi: 10.1007/BF01477498. [DOI] [PubMed] [Google Scholar]
  8. Digenis G., Pierratos A., Oreopoulos D. G. Cancer and chronic renal failure. CMAJ. 1986 Jul 1;135(1):14–16. [PMC free article] [PubMed] [Google Scholar]
  9. Egido J., Sánchez-Crespo M., Picazo J. J., Gómez M. F., Losada M., Hernando L. DNA release and appearance of antinuclear antibodies in chronic hemodialysis patients. Nephron. 1982;31(2):164–169. doi: 10.1159/000182637. [DOI] [PubMed] [Google Scholar]
  10. Emlen W., Burdick G. Clearance and organ localization of small DNA anti-DNA immune complexes in mice. J Immunol. 1988 Mar 15;140(6):1816–1822. [PubMed] [Google Scholar]
  11. Emlen W., Mannik M. Effect of DNA size and strandedness on the in vivo clearance and organ localization of DNA. Clin Exp Immunol. 1984 Apr;56(1):185–192. [PMC free article] [PubMed] [Google Scholar]
  12. Emlen W., Mannik M. Kinetics and mechanisms for removal of circulating single-stranded DNA in mice. J Exp Med. 1978 Mar 1;147(3):684–699. doi: 10.1084/jem.147.3.684. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Fournié G. J. Circulating DNA and lupus nephritis. Kidney Int. 1988 Feb;33(2):487–497. doi: 10.1038/ki.1988.25. [DOI] [PubMed] [Google Scholar]
  14. Fournié G. J., Lulé J., Dueymes J. M., Laval F., Delobbe I., Vernier I., Pourrat J. P. Plasma DNA in patients undergoing hemodialysis or hemofiltration: cytolysis in artificial kidney is responsible for the release of DNA in circulation. Am J Nephrol. 1989;9(5):384–391. doi: 10.1159/000168000. [DOI] [PubMed] [Google Scholar]
  15. Hardin J. A., Craft J. E. Patterns of autoimmunity to nucleoproteins in patients with systemic lupus erythematosus. Rheum Dis Clin North Am. 1987 Apr;13(1):37–46. [PubMed] [Google Scholar]
  16. Horgan C., Johnson R. J., Gauthier J., Mannik M., Emlen W. Binding of double-stranded DNA to glomeruli of rats in vivo. Arthritis Rheum. 1989 Mar;32(3):298–305. doi: 10.1002/anr.1780320311. [DOI] [PubMed] [Google Scholar]
  17. Kornberg R. D. Structure of chromatin. Annu Rev Biochem. 1977;46:931–954. doi: 10.1146/annurev.bi.46.070177.004435. [DOI] [PubMed] [Google Scholar]
  18. McCoubrey-Hoyer A., Okarma T. B., Holman H. R. Partial purification and characterization of plasma DNA and its relation to disease activity in systemic lupus erythematosus. Am J Med. 1984 Jul;77(1):23–34. doi: 10.1016/0002-9343(84)90431-5. [DOI] [PubMed] [Google Scholar]
  19. McGhee J. D., Felsenfeld G. Nucleosome structure. Annu Rev Biochem. 1980;49:1115–1156. doi: 10.1146/annurev.bi.49.070180.005343. [DOI] [PubMed] [Google Scholar]
  20. Morimoto C., Sano H., Abe T., Homma M., Steinberg A. D. Correlation between clinical activity of systemic lupus erythematosus and the amounts of DNA in DNA/anti-DNA antibody immune complexes. J Immunol. 1982 Nov;129(5):1960–1965. [PubMed] [Google Scholar]
  21. Pancer L. B., Milazzo M. F., Morris V. L., Singhal S. K., Bell D. A. Immunogenicity and characterization of supernatant DNA released by murine spleen cells. J Immunol. 1981 Jul;127(1):98–104. [PubMed] [Google Scholar]
  22. Rumore P. M., Steinman C. R. Endogenous circulating DNA in systemic lupus erythematosus. Occurrence as multimeric complexes bound to histone. J Clin Invest. 1990 Jul;86(1):69–74. doi: 10.1172/JCI114716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Sipes J. N., Suratt P. M., Teates C. D., Barada F. A., Davis J. S., Tegtmeyer C. J. A prospective study of plasma DNA in the diagnosis of pulmonary embolism. Am Rev Respir Dis. 1978 Sep;118(3):475–478. doi: 10.1164/arrd.1978.118.3.475. [DOI] [PubMed] [Google Scholar]
  24. Sollner-Webb B., Camerini-Otero R. D., Felsenfeld G. Chromatin structure as probed by nucleases and proteases: evidence for the central role of histones H3 and H4. Cell. 1976 Sep;9(1):179–193. doi: 10.1016/0092-8674(76)90063-5. [DOI] [PubMed] [Google Scholar]
  25. Steinman C. R., Ackad A. Appearance of circulating DNA during hemodialysis. Am J Med. 1977 May;62(5):693–697. doi: 10.1016/0002-9343(77)90872-5. [DOI] [PubMed] [Google Scholar]
  26. Steinman C. R. Circulating DNA in systemic lupus erythematosus. Association with central nervous system involvement and systemic vasculitis. Am J Med. 1979 Sep;67(3):429–435. doi: 10.1016/0002-9343(79)90789-7. [DOI] [PubMed] [Google Scholar]
  27. Steinman C. R. Detection and semiquantitation of DNA by counterimmunoelectrophoresis (CIE). Methods Enzymol. 1982;84:187–193. doi: 10.1016/0076-6879(82)84016-0. [DOI] [PubMed] [Google Scholar]
  28. Steinman C. R. Free DNA in serum and plasma from normal adults. J Clin Invest. 1975 Aug;56(2):512–515. doi: 10.1172/JCI108118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. TSUMITA T., IWANAGA M. Fate of injected deoxyribonucleic acid in mice. Nature. 1963 Jun 15;198:1088–1089. doi: 10.1038/1981088a0. [DOI] [PubMed] [Google Scholar]
  30. Taylor R. P., Kujala G., Edberg J. C., Foreman P., Davis J. S., 4th, Wright E. The kinetics of clearance of human antibody/dsDNA immune complexes from rabbit circulation. Effects of dsDNA size, rheumatoid factor, and reduction and alkylation of the antibodies. J Immunol. 1986 May 15;136(10):3785–3792. [PubMed] [Google Scholar]
  31. Taylor R. P., Kujala G., Wilson K., Wright E., Harbin A. In vivo and in vitro studies of the binding of antibody/dsDNA immune complexes to rabbit and guinea pig platelets. J Immunol. 1985 Apr;134(4):2550–2558. [PubMed] [Google Scholar]
  32. Wyllie A. H. Apoptosis: cell death in tissue regulation. J Pathol. 1987 Dec;153(4):313–316. doi: 10.1002/path.1711530404. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES